Health Care · Pharmaceutical Preparations · NYSE · CIK 1708599 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $2.04Day −1.45%Mkt cap $31M1Y −62.6%Off 52W high −74.2%Vol (1Y) 138.0%
Daily closing price, split-adjusted to the current basis; 2.3y shown of 584 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest1.9% of sh out |
| Days to cover5.2d |
| 13F net flow (QoQ)+0.51% |
| Top-10 13F concentration99.6% |
| Next report (est.)2026-08-16 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$130,000 |
| Earnings (TTM)-$21.3M |
| Net margin−14755.4% |
| Sales growth 3Y56.4% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+6.6% |
| 1Y−62.6% |
| Since incept. (ann.)−57.2% |
Total return through 2026-07-30 · series begins 2024-03-27. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)138.0% |
| Ann. volatility (3Y)118.2% |
| Sharpe (1Y)−0.22 |
| Sharpe (3Y)−0.20 |
| Max drawdown (1Y)−78.5% |
| Max drawdown (3Y)−91.4% |
| Beta (3Y vs SPY)−0.03 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Sio Capital Management, LLC | 1.0M | $2M | 8.12% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 159,136 | $308,724 | 1.29% | new |
| Waverly Advisors, LLC | 67,492 | $130,934 | 0.55% | +0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 64,973 | $126,049 | 0.53% | +113.7% |
| BlackRock, Inc. | 58,264 | $113,033 | 0.47% | +237.8% |
| JANE STREET GROUP, LLC | 39,653 | $76,927 | 0.32% | new |
| VANGUARD FIDUCIARY TRUST CO | 20,009 | $38,817 | 0.16% | new |
| Avidian Wealth Enterprises, LLC | 18,800 | $36,472 | 0.15% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$0.58 | — | — | — |
| 2025-12-31 | 2026-03-25 | — | — | $0 | — |
| 2025-09-30 | 2025-11-13 | −$0.45 | −446.2% | $0 | −100.0% |
| 2025-06-30 | 2025-08-11 | −$0.66 | −229.4% | $130,000 | +154.9% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-16 is ESTIMATED from filing cadence (median gap 94d) — not company-confirmed.
Reportable 100%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
